NASHVILLE--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it has entered into a definitive agreement with Samsung Bioepis Co. Ltd. (hereafter “Samsung Bioepis”) to secure the exclusive U.S. commercial rights to the ophthalmology biosimilar portfolio of Samsung Bioepis — BYOOVIZ® (ranibizumab-nuna), an FDA-approved biosimilar referencing LUCENTISi (ranibizumab), and OPUVIZ™ (aflibercept-yszy), an FDA-approved biosimilar refer.

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced the expanded launch of their innovative concierge-like service designed to specifically improve medication adherence for Medicare beneficiaries managing multiple chronic conditions and complex medication regimens. SelectQuote's SelectRx pharmacy recently trialed a new approach with.

Announces Second Quarter 2025 Earnings Release and Conference Call Schedule HOUSTON , July 17, 2025 /PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) ("Main Street" or the "Company") is pleased to announce its preliminary operating results for the second quarter of 2025 and its second quarter 2025 earnings release and conference call schedule. In commenting on the Company's preliminary operating results for the second quarter of 2025, Dwayne L.

94 MW Solar Facility Holds Power Purchase Agreement with Constellation KITCHENER, ON , July 17, 2025 /PRNewswire/ -- Recurrent Energy, a subsidiary of Canadian Solar Inc. ("Canadian Solar") (NASDAQ: CSIQ) and a global developer, owner, and operator of solar and energy storage assets, announced today it has closed project financing and tax equity for Blue Moon Solar. U.S. Bank, through its subsidiary U.S. Bancorp Impact Finance, is providing both tax equity and construction financing for the project, totaling $260 million.

Approval Follows Successful Pre-IND Meeting with the U.S. FDA on iTOL-102, a Potential Cure for Type 1 diabetes that would circumvent the need for life-long immunosuppression drugs ZURICH , July 17, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP) ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system disorders, today announced that the Israel-U.S. Binational Industrial Research and Development Foundation (the "Bird Foundation") has approved another milestone-based funding payment to Kadimastem Ltd.

MINNEAPOLIS , July 17, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 6, 2025, at 8:00 a.m. CDT to review its fourth quarter and fiscal 2025 financial results.

it's been nearly three months since gold climbed past $3,500 an ounce to its highest price on record, but five key factors to emerge since the start of President Donald Trump's second term are likely to support prices in the months ahead.

SANTA ANA, Calif. , July 17, 2025 /PRNewswire/ -- Identiv, Inc. (NASDAQ: INVE), a global leader in RFID- and BLE-enabled Internet of Things (IoT) solutions, will hold a teleconference and webcast on Thursday, August 7, 2025, at 5:00 PM EDT to discuss its financial results for the second quarter ended June 30, 2025.

QuidelOrtho Announces Featured ADLM Session SAN DIEGO , July 17, 2025 /PRNewswire/ -- How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.

TORONTO, July 17, 2025 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) will release its second quarter 2025 results before markets open on Monday, August 11, 2025 at approximately 6:00 AM EDT. President and CEO Mark Bristow will host a webcast to discuss the results at 11:00 AM EDT followed by a question-and-answer session with analysts.

China's central bank has been buying physical gold to add to its reserves for at least the last three years – and there's growing speculation that the country may be purchasing even more of the metal in secret as part of a strategy to reduce its reliance on the U.S. dollar.

HOLLISTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced a CEO succession plan under which John Duke will assume the role of President & CEO following the planned retirement of Jim Green, effective July 28, 2025. Jim Green will be retiring from his President, CEO & Chairman roles at Harvard Bioscience after more than 8 years as Chairman and 6 years as President & CEO.

CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) ("Chicago Atlantic" or the “Company”), a commercial mortgage real estate investment trust, announced details for the release of its results for the second quarter ended June 30, 2025.

ATLANTA, July 17, 2025 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, will issue its second quarter 2025 financial results on Thursday, August 7, 2025 prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day.

Miami, FL, July 17, 2025 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced it will release financial results for the second quarter 2025 before the market opens on Thursday, August 7, 2025. Management will host a webcast and conference call that same day at 10:00 a.m. Eastern time to review the Company's results.

GREENWICH, Conn., July 17, 2025 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) will hold its second quarter 2025 earnings conference call and webcast on Wednesday, August 6, 2025, at 8:30 a.m. Eastern Time. The company's results will be released after market close on Tuesday, August 5, 2025, and made available at that time on investors.gxo.com.

MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results.

I focus on wide-moat, growth-driven, financially robust companies trading below fair value, following Buffett's simplicity philosophy for long-term investing. Salesforce, ASML, and Equinix each lead their industries, benefit from strong secular trends, and offer sustainable dividend growth with low payout ratios. All three boast investment-grade credit ratings and robust balance sheets and are currently trading at attractive discounts to fair value estimates.

ROCKVILLE, Md., July 17, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that it entered into a definitive agreement to acquire 100% ownership of Bridge Health Biotech Co., Ltd. (Bridge Health). The transaction provides I-Mab with the rights to bispecific and multi-specific applications (including bispecific and multi-specific antibodies and antibody drug conjugates (ADCs)), based on the Claudin 18.2 (CLDN18.2) parental antibody used in the Company's CLDN18.2 x 4-1BB bispecific antibody, givastomig.

Lantronix's new NTC-500 Series enables enterprises to achieve next-gen mobility, real-time insights and improved ROI Lantronix's new NTC-500 Series enables enterprises to achieve next-gen mobility, real-time insights and improved ROI